13F Holdings
中文EN

VJET Flyte Aviation, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1716621 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY599.8%
TTM net income YoY-51.9%
TTM EPS YoY89.8%
Revenue 3-yr CAGR124.0%
Net income 3-yr CAGR—

Margins

Gross margin29.2%
Operating margin-527.1%
Net margin-733.4%
FCF margin-331.6%
EBITDA margin-499.9%

Returns

ROE-273.6%
ROA-104.1%
ROIC (approx.)-173.4%
Asset turnover0.14x

Leverage & solvency

Liabilities / assets51.7%
Debt / equity0.00x
Current ratio0.54x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.45x
Accruals ratio-57.1%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$819,000$420,000$442,000$14,000$22,000
Cost of revenue$63,000$42,000$30,000$161,000$1.56M
Gross profit$756,000$378,000$412,000-$147,000-$1.54M
R&D expense$862,000$272,000$475,000$6.39M$12.25M
SG&A expense$12.07M$11.35M$17.12M$16.25M$15.47M
Operating income-$21.14M-$11.24M-$78.12M-$26.96M-$29.27M
Pretax income-$19.50M-$13.50M-$70.57M-$26.86M-$27.26M
Income tax-$1.81M$3.14M$0$3,000$4,000
Net income-$17.18M-$16.64M-$70.57M-$26.86M-$25.07M
EBITDA-$19.03M-$9.13M-$76.04M-$26.54M-$27.70M
EPS (basic)-15.90-126.91-129.88-25.98-248.22
EPS (diluted)———-25.98-248.22
Weighted avg. shares (diluted)———1.03M101,000
Balance sheet
Cash & equivalents$88,000$2.87M$3.56M$15.86M$15.04M
Short-term investments$0————
Receivables$155,000$70,000$137,000$0$21,000
Inventory$86,000$33,000$44,000$0$986,000
Current assets$390,000$3.29M$4.16M$16.84M$17.09M
PP&E, net$0$91,000$70,000$0$1.81M
Goodwill$0—$0$0—
Intangibles$0$24.27M$26.32M$0—
Total assets$15.86M$27.77M$30.74M$16.84M$21.04M
Current liabilities$3.91M$2.23M$2.47M$7.58M$5.39M
Short-term debt$0————
Long-term debt$3.08M————
Total debt$3.08M————
Total liabilities$9.21M$16.01M$9.54M$7.58M$7.37M
Shareholders' equity$7.05M$11.76M$21.19M$9.26M$13.67M
Net debt$2.99M————
Shares outstanding173,896421,296702,6622.16M140,000
Cash flow statement
Operating cash flow-$8.30M-$9.27M-$20.62M-$22.57M-$27.62M
Capital expenditure$17,000$67,000$76,000$17,000$265,000
Free cash flow-$8.31M-$9.34M-$20.70M-$22.59M-$27.89M
Investing cash flow$167,000-$67,000-$61,000$21,000$3.80M
Financing cash flow$5.34M$8.65M$8.39M$23.36M$14.96M
Depreciation & amortization$2.12M$2.11M$2.08M$421,000$1.56M
Stock-based compensation$338,000$54,000$1.22M$447,000$2.24M

Free plan shows the latest 5 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.